bpc-157 fda warning unapproved drug An advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with FDA Panel Endorses Lifting Restrictions

WADA does not state why it has banned BPC-157, but presumably there are concerns about the lack of research into its safety and the (also unresearched) possibility that it does indeed enhance athletic performance

Individuals With Malabsorption Conditions Certain medical conditions and medications can interfere with B12 absorption, including: Pernicious anemia (an autoimmune condition that impairs intrinsic factor production necessary for B12 absorption)[12]

In the context of senescence, SnCs seem to use the same mechanism to avoid their elimination by macrophages 47

When reconstituted with bacteriostatic water and stored properly between 2C and 8C (36F and 46F), Retatrutide is typically stable for research use for up to four weeks